GLI1 and ovarian cancer: The inhibition of GLI1 following chemotherapy may serve as a novel strategy to ensure the crucial killing effect of chemotherapy on tumour cells and inhibit the chemotherapy-exacerbated metastasis in ovarian cancer treatment.